The Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT) in Palermo is a joint public-private partnership between UPMC, the Region of Sicily, and Civico and Cervello hospitals. Since its establishment in 1997, ISMETT has become one of the leading transplant centers and specialty hospitals in Europe, performing more than 2,000 transplants to date. Its specialists work closely with UPMC’s world-renowned transplantation teams and are supported by advanced diagnostic services, offering patients the most sophisticated therapies available.
ISMETT also provides specialized surgical, radiologic, and endoscopic procedures for patients with complex diseases. Exploring clinical treatment alternatives to transplantation ensures that the most sophisticated therapies are available to our patients.
UPMC and ISMETT together also support biomedical research projects, such as The Cell Factory. The Cell Factory consists of three laboratories dedicated to the production of cells to treat end-stage organ failure. Projects such as these are helping to fuel scientific and medical excellence in southern Italy.
The Ri.MED Foundation is a biomedical research and biotechnology center co-founded in 2006 by UPMC, the University of Pittsburgh School of Medicine, and the Italian government. Ri.MED promotes, supports, and leads research projects with an emphasis on translating innovative results into clinical practice. Located in Palermo, Ri.MED has broken ground on the Biomedical Research and Biotechnology Center (BRBC), which will investigate the most contemporary topics in biomedical research and is expected to become a reference point for researchers from all over the world.
UPMC Salvator Mundi International Hospital (SMIH), a private hospital located in the center of Rome, joined the UPMC family in 2018 with the goal of enhancing and expanding their services across multiple specialties including oncology; cardiology; and physiotherapy and rehabilitation. SMIH has served both local and international patients in the Rome region since 1951. Together with UPMC, SMIH will seek to provide patients with the most advanced clinical services available.
With multiple locations in the U.S., Ireland, and Italy, UPMC Hillman Cancer Center offers world-class cancer treatments backed by best practices and leading protocols. Patients are supported by a connected team of international cancer experts who use the latest medical equipment and technology to create tailored treatment plans for each unique case.
Operated by UPMC since 2013, UPMC Hillman Cancer Center at San Pietro FBF is a collaboration with San Pietro Fatebenefratelli, a 500-bed hospital located in Rome. Today, the facility is acknowledged as a radiotherapy center of excellence and has sustained accreditation from the Joint Commission International since 2017.
Opened in 2018, UPMC Hillman Cancer Center at Villa Maria is a collaboration with Casa di Cura Villa Maria, a 92-bed nationally-accredited private hospital located in Mirabella Eclano (Campania region). The facility offers both private and public patients accessible, high-quality radiotherapy treatments for oncology diseases.